🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Juvenile Idiopathic Arthritis

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions NCT04833465n/a1 site📍 Washington D.C. Children's National Research Institute · Tests: No Intervention Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents NCT07554495Phase 314 sites📍 Leuven📍 Prague📍 Le Kremlin-Bicêtre Alfasigma S.p.A. · Tests: Filgotinib A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease NCT07203001Phase 223 sites📍 Cincinnati📍 Portland📍 Salt Lake City Novartis Pharmaceuticals · Tests: MAS825 Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis NCT06874608NA1 site📍 Florence Meyer Children's Hospital IRCCS · Tests: complete, polymeric formula, fiber, lactose and gluten free Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty NCT07138898Phase 21 site📍 New York NYU Langone Health · Tests: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide, Azathioprine Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis. NCT07845942n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS NCT03728478Phase 31 site📍 Genova Istituto Giannina Gaslini · Tests: Etanercept, Methotrexate, Intra-articular corticosteroid injections Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis NCT06806774n/a2 sites📍 Ankara📍 Ankara Hacettepe University A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis NCT06869551Phase 348 sites📍 Lancaster📍 Chicago📍 Indianapolis Bristol-Myers Squibb · Tests: Deucravacitinib, Placebo Tofacitinib in Juvenile Idiopathic Arthritis NCT07211932n/a7 sites📍 A Coruña📍 Badalona📍 Barcelona Consorci Sanitari de l'Alt Penedès i Garraf · Tests: Tofacitinib Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis NCT07234747NA1 site📍 Istanbul Istanbul University - Cerrahpasa · Tests: Structured Core Stabilization Exercise Training, Exergaming-Based Core Stabilization Training Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients NCT07185750n/a1 site📍 Çankaya Hacettepe University · Tests: Questionnaire application for JIA cases and their parents Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases NCT07087912Phase 42 sites📍 São Paulo📍 São Paulo University of Sao Paulo General Hospital · Tests: Dengue 1,2,3,4 (attenuated) vaccine EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases NCT07077304n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: observational study Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study. NCT06862843n/a4 sites📍 Florence📍 Roma📍 Foggia Meyer Children's Hospital IRCCS · Tests: Collecting questionnaires and biological samples Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional Study. NCT07799831n/a1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine Pain in Inflammatory Joint Diseases NCT06718569n/a1 site📍 Oslo Diakonhjemmet Hospital · Tests: Biological or targeted synthetic DMARD UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease NCT06560606n/a19 sites📍 Calgary📍 Edmonton📍 Vancouver The Hospital for Sick Children Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions NCT03510442n/a1 site📍 Bethesda National Institute of Arthritis and Musculoskeletal and Ski… Health and Exercise Response in Children With Chronic and Auto-immune Pathologies NCT03913962NA1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: indirect calorimetry OLE Study With Filgotinib in JIA NCT07553182Phase 34 sites📍 Le Kremlin-Bicêtre📍 Hamburg📍 Sankt Augustin Alfasigma S.p.A. · Tests: Filgotinib Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Virtual Self-Management Program for JIA NCT06184100NA1 site📍 Calgary University of Calgary · Tests: Virtual Self-Management Program (SMP), No Intervention Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases NCT07184450Phase 11 site📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: BCMA/CD70-targetd CAR-T Ilaris NIS in Korea NCT06838143n/a1 site📍 Seoul Novartis Pharmaceuticals · Tests: Ilaris A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis NCT03773965Phase 378 sites📍 Rosario📍 SAN M. de Tucuman📍 Melbourne Eli Lilly and Company · Tests: Baricitinib Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea NCT07243782n/a1 site📍 Seoul Novartis Pharmaceuticals · Tests: Secukinumab Development of a Multidimensional Prediction Model for the Course and Outcome of Early-Onset Juvenile Idiopathic Arthritis (JIA) NCT07882667n/a2 sites📍 Genova📍 Lecce Istituto Giannina Gaslini Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial NCT06653634Phase 47 sites📍 Bergen📍 Drammen📍 Kristiansand Oslo University Hospital · Tests: Methotrexate, TNF Inhibitor
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy